BCPC

Balchem Corporation

Fundamental data last updated:June 19, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Chemicals - Specialty

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

07/30/2026

Business Summary

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

 


Analyze BCPC on TradingView

VALUATION

P/E

32.73

Market Cap ($M USD)

$5.15B

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

4.87

PRICE TO BOOK

4.03

EV / EBITDA

19.37

5-Year Average P/E

Free Cash Flow Yield

3.42%

DCF Value

$169.36

Graham Number

$66.22

Price to FCF

29.26

EV to FCF

29.90

Earnings Yield

3.06%

FCF Yield

3.42%

DIVIDEND

Yield

0.60%

Annual Payout

$0.96

Payout Ratio

19.48%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$4.90

Next Year EPS Growth Estimate

$0.00

Next Year Revenue Growth Estimate

$130.20B

Return on Equity (ROE)

12.38%

FREE CASH FLOW

Operating Margin

20.97%

Debt-to-Equity

0.15

Piotroski F-Score

9

Altman Z-Score

9.79

Return on Invested Capital (ROIC)

14.39%

Current Ratio

2.55

Quick Ratio

1.59

Net Debt to EBITDA

0.41

Interest Coverage

21.32

Gross Profit margin

36.27%

FCF PER SHARE

$5.45

REVENUE PER SHARE

$32.75

Analyze BCPC on TradingView

Gainseekers Quantitative Analysis

Summary

Balchem Corporation’s valuation presents a mixed picture. The stock has traded below its DCF value, suggesting potential undervaluation, yet its Price/Earnings ratio is elevated, indicating high market expectations. The Altman Z-score of 9.7 underscores financial stability, while the absence of a Forward P/E raises questions about future earnings visibility. Despite a modest earnings yield, the company’s robust ROIC of 14.39% highlights efficient capital use, suggesting management is adept at generating returns. Overall, the market may be underestimating its intrinsic value, but caution is warranted given the high valuation multiples.

AI Exposure / Tech Reliance

Operating in the Chemicals - Specialty sector, Balchem is well-positioned to leverage AI and modern technology to enhance production efficiency and product innovation. The industry’s focus on specialty chemicals allows for tailored solutions, which can be optimized through advanced data analytics. This adaptability ensures resilience in a rapidly evolving tech landscape.

The Bull Case

For the discerning GARP investor, Balchem offers compelling strengths. A Piotroski F-Score of 9 indicates strong financial health, while a 20.97% operating margin reflects significant pricing power. The ROIC of 14.39% suggests superior capital efficiency, and a manageable Debt/Equity ratio of 0.15 enhances its appeal. Despite a modest FCF yield, the company’s ability to generate cash flow supports its growth narrative, making it an attractive buy for those seeking quality at a reasonable price.

The Bear Case

Despite its strengths, Balchem's valuation metrics raise red flags. The Price/Sales ratio of 4.89 and Price/Book ratio of 4.04 suggest the stock is priced for perfection, leaving little room for error. Its earnings surprise percentage indicates potential volatility, and the stock's proximity to its 52-week high suggests technical overextension. Additionally, the EV to EBITDA multiple of 19.46 is steep, implying the market may be overestimating its growth prospects.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$162.00

Institutional Ownership %

1-Year Beta

0.85

Insider Buying % (6 Mo)

Distance to 52-Week High

14.75%

Distance to 52-Week Low

13.16%

EARNINGS SURPRISE %

-12.59%

50-DAY SMA

$167.24

200-DAY SMA

$161.83

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.